Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-14FDA Approved: MOMETASONE FUROATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for mometasone furoate from Glenmark Pharmaceuticals Inc., USA under an ANDA.
-
FDA approval · 2024-06-12FDA Approved: ADBRY — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for ADBRY (tralokinumab-ldrm) submitted by LEO Pharma Inc.
-
FDA approval · 2024-05-29FDA Approved: HALCINONIDE TOPICAL SOLUTION — Original Application (INA Pharmaceutics Inc)
FDA approved the Original Application for halcinonide topical solution from INA Pharmaceutics Inc, a generic version.
-
FDA approval · 2024-04-30FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (The J. Molner Company LLC)
FDA approves a supplemental application for hydrocortisone butyrate (ANDA 209556) by The J. Molner Company LLC. The approval updates the pro…
-
FDA approval · 2024-04-26FDA Approved: RINVOQ — Original Application (AbbVie Inc.)
The FDA approved Rinvoq (upadacitinib) from AbbVie under an Original Application NDA, granting the drug its initial US marketing authorizati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-10FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Aurobindo Pharma Limited)
FDA approved Betamethasone dipropionate topical from Aurobindo Pharma Limited under an original ANDA for inflammatory and pruritic corticost…
-
FDA approval · 2024-01-25FDA Approved: DUPIXENT — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Dupixent (dupilumab) filed by Sanofi‑Aventis U.S. LLC, indicating an approval of a supplement re…
-
FDA approval · 2023-12-28FDA Approved: CLOBETASOL PROPIONATE ANDA — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved the original ANDA for clobetasol propionate topical from Macleods Pharmaceuticals Limited, enabling a generic version of th…
-
FDA approval · 2023-12-14FDA Approved: ADBRY — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for ADBRY (tralokinumab-ldrm) by LEO Pharma Inc., indicating a change to labeling or indication.
-
FDA approval · 2023-12-14FDA Approved: CIBINQO — Supplemental Application (U.S. Pharmaceuticals)
FDA approved a supplemental application for CIBINQO (abrocitinib) filed by U.S. Pharmaceuticals.
-
FDA approval · 2023-12-14FDA Approved: CYCLOSPORINE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva Pharmaceuticals' generic cyclosporine under an original application (ANDA 203880), expanding access to this immunosuppress…
-
FDA approval · 2023-12-05FDA Approved: PREDNISONE TABLETS, USP, 5 MG — Supplemental Application (Granulation Technology, Inc.)
FDA granted a supplemental approval for Prednisone Tablets, USP, 5 mg to authorize a granulation technology manufacturing change by Granulat…
-
FDA approval · 2023-11-29FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for clobetasol propionate, a potent topical corticosteroid, enabling an approved supplement…
-
FDA approval · 2023-10-10FDA Approved: TACROLIMUS — Original Application (Encube Ethicals, Inc.)
FDA approved Encube Ethicals, Inc.'s tacrolimus ointment 0.1% as a generic product for the treatment of atopic dermatitis.
-
FDA approval · 2023-08-23FDA Approved: DESOXIMETASONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for desoximetasone from Padagis Israel Pharmaceuticals Ltd, finalizing an update to the approved AND…
-
FDA approval · 2023-07-17FDA Approved: HYDROCORTISONE — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for hydrocortisone by Aurobindo Pharma Limited, marking the first approval of this generic product.
-
FDA approval · 2023-06-02FDA Approved: ADBRY — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for ADBRY (tralokinumab-ldrm) submitted by LEO Pharma Inc.
-
FDA approval · 2023-04-18FDA Approved: BETAMETHASONE VALERATE — Original Application (Xiromed, LLC.)
FDA approved Xiromed, LLC's Betamethasone Valerate Foam as an original ANDA, establishing a generic version of betamethasone valerate foam f…
-
FDA approval · 2023-04-03FDA Approved: EUCRISA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for EUCRISA (crisaborole) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2022-07-27FDA Approved: ADBRY — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for Adbry (tralokinumab-ldrm) from LEO Pharma Inc. The approval results in updated labeling for the …
-
FDA approval · 2022-05-31FDA Approved: FLUOCINOLONE ACETONIDE OIL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Fluocinonide Acetonide Oil from Rising Pharma Holdings, Inc., a topical corticosteroid produ…
-
FDA approval · 2022-02-18FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)
FDA approved the Original Application for Betamethasone Dipropionate USP, 0.05% (topical corticosteroid) submitted by TruPharma LLC. It is a…
-
FDA approval · 2022-02-17FDA Approved: CLOBETASOL PROPIONATE — Original Application (Quagen Pharmaceuticals LLC)
FDA approved the original application for a generic clobetasol propionate topical product by Quagen Pharmaceuticals LLC.
-
FDA approval · 2022-01-14FDA Approved: CIBINQO — Original Application (U.S. Pharmaceuticals)
FDA approved CIBINQO (abrocitinib) through an original New Drug Application from U.S. Pharmaceuticals. It is indicated for the treatment of …
-
FDA approval · 2021-12-27FDA Approved: ADBRY — Original Application (LEO Pharma Inc.)
FDA approved ADBRY (tralokinumab-ldrm) through an original Biologics License Application filed by LEO Pharma Inc.